TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Tataa Biocenter AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
52,159
|
36,724
|
94,211 |
Financial expenses |
7
|
359
|
3 |
Earnings before taxes |
-60,357
|
-60,507
|
-10,893 |
EBITDA |
-54,522
|
-54,490
|
4,179 |
Total assets |
43,799
|
44,339
|
69,065 |
Current assets |
26,782
|
22,667
|
43,878 |
Current liabilities |
14,295
|
26,601
|
42,768 |
Equity capital |
29,504
|
17,738
|
26,297 |
- share capital |
139
![]() |
139
![]() |
139 |
Employees (average) |
46
|
47
|
41 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
67.4%
|
40.0%
|
38.1% |
Turnover per employee |
1,134
|
781
|
2,298 |
Profit as a percentage of turnover |
-115.7%
|
-164.8%
|
-11.6% |
Return on assets (ROA) |
-137.8%
|
-135.7%
|
-15.8% |
Current ratio |
187.4%
|
85.2%
|
102.6% |
Return on equity (ROE) |
-204.6%
|
-341.1%
|
-41.4% |
Change turnover |
15,435
|
-57,487
|
13,506 |
Change turnover % |
42%
|
-61%
|
17% |
Chg. No. of employees |
-1
|
6
|
13 |
Chg. No. of employees % |
-2%
|
15%
|
46% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.